UK-Myanmar teledermatology trial bridges a skin-care gap

A single dermatologist serves, on average, roughly one million people in Myanmar, according to the Journal of Investigative Dermatology. For most of the country's 54 million residents, a skin condition goes undiagnosed for years — or indefinitely.

The journal reported on a teledermatology initiative connecting UK-based dermatologists with patients in Myanmar, a Southeast Asian country the World Bank ranks among the lowest globally for gross national income. The project is an attempt to move specialist care across a distance that geography and economics have made, until now, nearly uncrossable.

A country shaped by compounding barriers

Myanmar carries what researchers describe as a particularly high burden of skin disease. The Journal of Investigative Dermatology cited environmental conditions, socioeconomic pressures, and severely limited healthcare access as the principal drivers. Decades of political instability have kept healthcare expenditure among the lowest recorded anywhere, according to figures the journal attributed to Tandon et al.

The country recognises more than 130 distinct ethnic groups, the WHO reported in 2023 — a demographic reality that shapes both language access and cultural trust in medical settings. For communities already underserved by the formal health system, dermatological care has been effectively out of reach.

Skin diseases rank as the fourth leading cause of non-fatal disease burden worldwide, according to research the journal cited from Hay et al. That figure carries particular weight for people with albinism, who face elevated and ongoing risk of sun-related skin damage with little access to specialist monitoring or early intervention.

What the initiative involves

The teledermatology model routes patient images and clinical notes from Myanmar to dermatologists in the UK, who provide diagnoses and treatment guidance remotely. The journal described the project as a structured attempt to test whether this kind of cross-border consultation is clinically viable at scale in a low- and middle-income country context.

The initiative does not replace local infrastructure. It works alongside the practitioners already present — community health workers, general physicians — giving them a channel to specialist knowledge they would not otherwise reach.

For people with albinism in Myanmar, the implications are specific. Skin surveillance — the regular checking of lesions, patches, and pigmentation changes — is standard care in countries with accessible dermatology services. In Myanmar, it has not been. A functioning teledermatology pathway could mean earlier detection of actinic keratoses and squamous cell carcinomas, the skin cancers to which people with albinism are disproportionately exposed.

The Journal of Investigative Dermatology presented the initiative as a model worth watching — early, partial, but grounded in the actual conditions of the country it serves.